QR Code

A three‐range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease

Abstract Introduction Alzheimer's disease consensus recommends biomarker dichotomization, a practice with well‐described clinical strengths and methodological limitations. Although neuroimaging studies have explored alternative biomarker interpretation strategies, a formally defined three‐range appr...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Wagner S. Brum, Marco Antônio deBastiani, Andrei Bieger, Joseph Therriault, João P. Ferrari‐Souza, Andréa L. Benedet, Paramita Saha‐Chaudhuri, Diogo O. Souza, Nicholas J. Ashton, Henrik Zetterberg, Tharick A. Pascoal, Thomas Karikari, Kaj Blennow, Pedro Rosa‐Neto, Eduardo R. Zimmer, Alzheimer's Disease Neuroimaging Initiative (ADNI)
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Wiley 2022-01-01
Rangatū:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Ngā marau:
Alzheimer's disease
CSF biomarkers
cut‐points
prognostic modeling
three‐range
Urunga tuihono:https://doi.org/10.1002/trc2.12270
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite